Executive readout · one minute
What the filings say
- 8-K earnings release · filed Nov 9, 2026
- Surgery Partners amended its merger agreement with HealthSpan Partners, increasing cash consideration to $25.00 per share and enterprise value to up to approximately $6.0 billion. Third-quarter revenue was $815.3 million, down (0.8)%, while Adjusted EBITDA was $132.7 million.
- 10-Q report · filed Nov 9, 2026
- Surgery Partners amended its merger agreement, providing $25.00 per share in cash plus a potential ticking fee. Third-quarter revenue fell 0.8% to $815.3 million and Adjusted EBITDA declined 2.7% to $132.7 million.
The audio replay and transcript follow the call.